|By PR Newswire||
|April 25, 2014 01:57 PM EDT||
LONDON, April 25, 2014 /PRNewswire/ --
On Thursday, April 24, 2014, the NASDAQ Composite ended at 4,148.34, up 0.52%, the Dow Jones Industrial Average finished the day flat at 16,501.65, and the S&P 500 closed at 1,878.61, up 0.17%. The gains were narrow based as four out of the ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 668.80, down 0.20%, whereas the index has advanced 3.81% in the previous three months. Investor-Edge has initiated coverage on the following equities: OPKO Health Inc. (NYSE: OPK), VCA Antech Inc. (NASDAQ: WOOF), Alere Inc. (NYSE: ALR) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA). Free technical research on OPK, WOOF, ALR and TEVA can be downloaded upon signing up at:
On Thursday OPKO Health Inc.'s stock edged 0.98% higher, to close the day at $8.24. The stock recorded a trading volume of 1.75 million shares, much below its three months average volume of 3.10 million shares. The stock oscillated between $8.10 and $8.32 during the session. Over the previous three trading sessions and the last three months, OPKO Health Inc.'s shares have fallen by 1.67% and 2.60%, respectively. Additionally, from the beginning of 2014, the company's stock has declined 2.37%. The stock is trading below its 50-day and 200-day moving averages. The company stock's 50-day moving average of 9.04 is above its 200-day moving average of $9.00. Additionally, the stock has an RSI of 36.80. Sign up today to read free research on OPK at:
On Thursday, shares in VCA Antech Inc. recorded a trading volume of 0.92 million shares, higher than its three months average volume of 0.66 million shares. The stock finished the day at $30.11, which was 2.24% below its previous day's closing of $30.11, and registered an intraday range of $30.00 and $31.00. Shares of the company traded at a PE ratio of 19.06. VCA Antech Inc.'s shares have declined 2.90% in the previous three trading sessions, 6.08% in the last three months, and 3.99% on YTD basis. The company's stock is trading above its 200-day moving average of $29.99. Furthermore, shares of the company have an RSI of 42.45. Sign up today to read free research on WOOF at:
Alere Inc.'s stock traded between $35.63 and $36.41 before ending the session 1.19% lower at $35.84, on Thursday. Alere Inc.'s stock reported a trading volume of 1.20 million shares, which is lower than its three months average volume of 0.78 million shares. Alere Inc.'s shares have declined 0.72% in the previous three trading sessions, 0.19% in the last one month. Moreover, the stock has fallen by 0.99% on YTD basis. The company's shares are trading above their 50-day and 200-day moving averages. The stock's 50-day moving average of $35.69 is greater than its 200-day moving average of $33.69. Alere Inc.'s stock has an RSI of 57.36. Sign up today to read free research on ALR at:
Shares in Teva Pharmaceutical Industries Ltd finished the Thursday's session 1.64% lower at $49.84. A total of 3.82 million shares were traded, which was below its three months average volume of 7.13 million shares. The stock moved between $49.80 and $50.57 during the session. Over the last one month and previous three months, Teva Pharmaceutical Industries Ltd's shares have advanced 1.45% and 16.10%, respectively. Further, the stock has surged 24.35% since the start of this year. The stock is trading above its 50-day and 200-day moving averages of $49.43 and $42.32, respectively. Moreover, shares of the company have an RSI of 51.34. Sign up today to read free research on TEVA at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.